Pharmaceutical companies with the most ‘New Product Exclusivity’ drugs

The chart depicts companies with the most New Product exclusivities granted by the FDA in the last five years. The FDA grants three years of exclusivity for categories like New Product Development and New Clinical Investigations. Other categories include identifying a New Patient Population, New Dosage Form, or New Strength.